The Georgia Department of Public Health (DPH), STD Office is requesting funding from CDC under the Notice of Funding Opportunity CDC-RFA-PS19-1901: Strengthening STD Prevention and Control for Health Departments (STD PCHD). In 2016, Georgia ranked 4th in the nation for primary and secondary syphilis, 3rd for gonorrhea, and 5th for Chlamydia. In 2017, increases in all three were observed: 65,243 cases of chlamydia, 22,756 cases of gonorrhea and 1,513 cases of primary and secondary syphilis (P&S) were reported to the STD Office. For syphilis, this represents a 37.41% increase from 2013 to 2017. From 2013-2017, the state has seen a significant uptick in every stage of syphilis: 39.20% in P&S cases; 34.99% in early latent cases; and 30.21% in late latent cases. Reported cases of congenital syphilis increased by 13.95% from 2013-2017.
Georgia’s STD Office will focus on the prevention and control of syphilis, gonorrhea and chlamydia. With this funding, the STD Office will implement new strategies, enhance existing strategies, and strengthen continued collaborations and establish new partnerships. Georgia’s STD prevention approach includes the supported strategies in this NOFO to: eliminate congenital syphilis; prevent antibiotic resistant gonorrhea; reduce primary and secondary syphilis; prevent STD-related pelvic inflammatory disease; ectopic pregnancy and infertility; address STD-related outbreaks; and reduce STD-related health disparities. The priority populations for the state include adolescents and young adults, men who have sex with men and pregnant women. The program intends to ensure that sufficient staff and analytic resources are maintained to meet the obligations outline in the NOFO.
The STD Office will also conduct ongoing evaluation and performance measurement over the course of the project period. It is expected that the program will have demonstrated measurable outcomes at various intervals of the five-year project period. By the end of project period, the program expects the following outcomes in the five strategy areas: 1) Improved completion and timeliness of data on reportable STDs through enhanced surveillance; 2) Increased treatment of patients and their partners and identification of persons living with HIV through enhanced disease investigation and intervention; 3) Increased education to promote CDC-recommended STD screenings, diagnosis and recommended treatment to bolster STD testing, timely treatment and identification of those living with HIV; 4) Increased availability of STD information and services for the public and provider community to promote STD prevention and health department policies for STD prevention and 5) Increased analysis and use data for more efficient targeting of STD prevention and care resources and services.